Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32141
Title: Differential diagnosis of familial adult myoclonic epilepsy.
Austin Authors: Baykan, Betul;Franceschetti, Silvana;Canafoglia, Laura;Cavalleri, Gianpiero L;Michelucci, Roberto;Scheffer, Ingrid E 
Affiliation: Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Istanbul, Turkiye.
Department of Diagnostic and Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Department of Diagnostic and Technology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
The School of Pharmacy and Biomolecular Sciences, the Royal College of Surgeons in Ireland, Dublin, Ireland.
IRCCS- Istituto delle Scienze Neurologiche di Bologna, Unit of Neurology and Epileptology, Bellaria Hospital, Bologna, Italy.
University of Melbourne, Royal Children's Hospitals, Florey and Murdoch Children's Research Institutes, Melbourne, Australia.
Epilepsy Research Centre
Issue Date: 8-Feb-2023
Date: 2023
Publication information: Epilepsia 2023; 64 Suppl 1
Abstract: Familial adult myoclonic epilepsy (FAME) is an under-recognized disorder characterized by cortical myoclonus, generalized tonic-clonic seizures and additional clinical symptoms, which vary depending on the FAME subtype. FAME is caused by pentanucleotide repeat expansions of intronic TTTCA and TTTTA in different genes. FAME should be distinguished from a range of differential diagnoses. The phenotypic features of FAME, including generalized tonic-clonic and myoclonic seizures, are also seen in other epilepsy syndromes, such as juvenile myoclonic epilepsy, with a resultant risk of misdiagnosis and lack of identification of the underlying cause. Cortical myoclonus may mimic essential tremor or drug-induced tremor. In younger individuals, the differential diagnosis includes progressive myoclonus epilepsies (PMEs), such as Unverricht-Lundborg disease; whereas, in adulthood, late-onset variants of PMEs, such as sialidoses, myoclonus epilepsy, and ataxia due to potassium channel pathogenic variants should be considered. PMEs may also be suggested by cognitive impairment, cerebellar signs, or psychiatric disorders. The EEG may show similarities to other idiopathic generalized epilepsies or PMEs, with generalized spike-wave activity. Signs of cortical hyperexcitability may be seen, such as an increased amplitude of somatosensory evoked potentials or enhanced cortical reflex to sensory stimuli, together with the neurophysiological pattern of the movement disorder. Recognition of FAME will inform prognostic and genetic counseling, and diagnosis of the insidious progression which may occur in older individuals who show mild cognitive deterioration. Distinguishing FAME from other disorders in individuals or families with this constellation of symptoms is essential to allow identification of the underlying aetiology.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32141
DOI: 10.1111/epi.17536
ORCID: 0000-0002-3360-659X
0000-0002-5385-761X
0000-0002-9802-0506
0000-0002-9655-7940
0000-0002-2311-2174
Journal: Epilepsia
PubMed URL: 36751956
ISSN: 1528-1167
Type: Journal Article
Subjects: Epilepsy
Myoclonic epilepsy
Appears in Collections:Journal articles

Show full item record

Page view(s)

48
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.